Quent Capital, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1912338 NEW YORK, NY

Position in NBIX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$21,910

-$2,857 QoQ

Shares Held

130

-30.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#664

of 775 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Quent Capital, LLC holds $2,423,759 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	4,104	$2,223,670
2	VTRS	Viatris Inc	3,722	$59,105
3	ALKS	Alkermes plc.	678	$35,527
4	ZTS	Zoetis Inc.	441	$31,690
5	NBIX	Neurocrine Biosciences Inc This page	130	$21,910
6	HIMS	Hims & Hers Health, Inc.	491	$17,022
7	INCR	Intercure Ltd.	2,064	$11,353
8	ELAN	Elanco Animal Health Inc	299	$7,358

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,910	130	-30.9%	Shares	Sole	2026-08-07
2026-03-31	$24,767	188	-23.3%	Shares	Sole	2026-04-28
2025-12-31	$34,748	245	+6.1%	Shares	Sole	2026-01-29
2025-09-30	$32,427	231	+212.2%	Shares	Sole	2025-10-27
2025-03-31	$8,184	74	0.0%	Shares	Sole	2025-04-04
2024-12-31	$10,101	74	-53.2%	Shares	Sole	2025-01-29
2024-09-30	$18,204	158	0.0%	Shares	Sole	2024-10-04
2024-06-30	$21,751	158	0.0%	Shares	Sole	2024-07-08
2024-03-31	$21,791	158	+285.4%	Shares	Sole	2024-06-28
2023-12-31	$5,402	41	+355.6%	Shares	Sole	2024-06-17
2023-09-30	$1,012	9	0.0%	Shares	Sole	2024-06-17
2023-06-30	$848	9	0.0%	Shares	Sole	2024-06-17
2023-03-31	$910	9	0.0%	Shares	Sole	2024-06-17
2022-12-31	$1,074	9	0.0%	Shares	Sole	2023-01-19
2022-09-30	$955	9	0.0%	Shares	Sole	2022-11-10
2022-06-30	$877	9	-91.7%	Shares	Sole	2022-08-08
2022-03-31	$10,218	109	+1111.1%	Shares	Sole	2022-05-12
2021-12-31	$766	9	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.